Home
>
National Drug Code (NDC)
>
Sildenafil
Sildenafil - 65162-351-09 - (Sildenafil)
Drug Information of Sildenafil
| Product NDC: | 65162-351 |
| Proprietary Name: | Sildenafil |
| Non Proprietary Name: | Sildenafil |
| Active Ingredient(s): | 20 mg/1 & nbsp; Sildenafil |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Sildenafil
| Product NDC: | 65162-351 |
| Labeler Name: | Amneal Pharmaceuticals LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA202025 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20121108 |
Package Information of Sildenafil
| Package NDC: | 65162-351-09 |
| Package Description: | 90 TABLET in 1 BOTTLE (65162-351-09) |
NDC Information of Sildenafil
| NDC Code | 65162-351-09 |
| Proprietary Name | Sildenafil |
| Package Description | 90 TABLET in 1 BOTTLE (65162-351-09) |
| Product NDC | 65162-351 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Sildenafil |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20121108 |
| Marketing Category Name | ANDA |
| Labeler Name | Amneal Pharmaceuticals LLC |
| Substance Name | SILDENAFIL |
| Strength Number | 20 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Phosphodiesterase 5 Inhibitor [EPC],Phosphodiesterase 5 Inhibitors [MoA] |
